Register
Login:
Share:
Email Facebook Twitter


Angus Energy announces transformational joint venture with Cuadrilla & Lucas Energy
Aim-listed Mongolian explorer Petro Matad to drill four wells in 2018


Genedrive Share Price (GDR)



Share Price Information for Genedrive (GDR)


Share Price: 33.50Bid: 32.00Ask: 35.00Change: 0.00 (0.00%)No Movement on Genedrive
Spread: 3.00Spread as %: 9.38%Open: 33.50High: 33.50Low: 33.50Yesterday’s Close: 33.50

Genedrive Plc Ord 1.5P

Genedrive is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
33.50

Share Price SpacerBid
32.00

Share Price SpacerAsk
35.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
0

Share Price SpacerOpen
33.50

Share Price SpacerHigh
33.50

Share Price SpacerLow
33.50

Share Price SpacerClose
33.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 18.69m £6.26m 1,000

52 Week High 43.50 52 Week High Date 10-APR-2017
52 Week Low 27.50 52 Week Low Date 16-JAN-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -0.960 -34.90 0.00 0.00


London South East Users info for Genedrive


Users who watch GDR also watch: Plant Impact, Redcentric, Ent. One Di, Accesso Tech, Costain, Xlmedia, Renew Holdings

Users who hold GDR also hold: Dixons Carpho, Barclays


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Feb-18
15:22:03
33.40
1,000
Sell* 
32.00
35.00
334.00
Trade Type:
Ordinary

20-Feb-18
12:11:38
33.40
2,958
Sell* 
32.00
35.00
987.97
Trade Type:
Ordinary

20-Feb-18
11:42:44
32.0301
1,123
Sell* 
32.00
35.00
359.70
Trade Type:
Ordinary




View more Genedrive trades >>

Directors Deals for Genedrive (GDR)
Trade DateActionNotifierPriceCurrencyAmountHolding
There is currently no Directors Deals information for Genedrive
View more Genedrive directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
14 Feb '18Ctw2014Results 20th March33.50No Opinion
...could bring news of initial sales of the HCV test which might give us a boost here.
6 Feb '18Ctw2014Hmmmmm34.00No Opinion
It is indeed possible that this could fall further, mainly because there is little volume and it only needs a few PIs to get impatient and sell to drop the price. On the other hand, at the first sniff of sales of the HCV test this will go up quite quickly imo. Lack of liquidity works in both directions. They have plenty of cash for now, and if they do sell the Services Division as proposed this will further boost the coffers. So I don’t see a fund raise anytime soon at these levels. If… Read More
5 Feb '18drafthmmmmm34.00No Opinion
i think this will drop further - that youtube mentioned a potential fund raise which was wiered given this has cash

Aslo selling the service line doesnt seem a bright idea at all.
5 Feb '18TroytoTiberRE: epistem34.00No Opinion
I think that this would relate to when epistem under old managementioned team took the newly developed genedrive unit for testing with becton dickinson in the US and it failed spectacularly. Faith in any commercial realisation at that point plummeted. Different story now though. (I hope!)
4 Feb '18draftepistem34.00No Opinion
why did share price crash back in 2014 - i cant find any old rnss
31 Jan '18Ctw2014£1.50 .....34.00No Opinion
....would suit me just fine.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Genedrive (GDR) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.